Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B LOWN

Showing results (131-140 of 263) with videos related to

Pageof 27
Sort By:
The American Journal of Cardiology|November 1, 1975
Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and releaseP J Axelrod, R L Verrier, B Lown
American Heart Journal|May 1, 1985
Side effects and complications of amiodarone therapyE A Raeder, P J Podrid, B Lown
Circulation Research|May 1, 1979
Central serotonergic agents raise the repetitive extrasystole threshold of the vulnerable period of the canine ventricular myocardiumC M Blatt, S H Rabinowitz, B Lown
The New England Journal of Medicine|September 4, 1980
Respiratory difficulty after use of disopyramideJ G Porterfield, E M Antman, B Lown
Cardiovascular Research|May 1, 1980
Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusionW W Brooks, R L Verrier, B Lown
Cardiovascular Research|March 1, 1978
Protective effect of the vagotonic action of morphine sulphate on ventricular vulnerabilityR A EdSilva, R L Verrier, B Lown
The American Journal of Cardiology|August 1, 1982
Effects of sulfinpyrazone on ventricular vulnerability in the normal and the ischemic heartE A Raeder, R L Verrier, B Lown
Circulation Research|June 1, 1977
Effect of stellectomy and vagotomy on ventricular refractoriness in dogsP J Schwartz, R L Verrier, B Lown
Journal of the American College of Cardiology|June 1, 1983
Intrinsic sympathomimetic activity and the effects of beta-adrenergic blocking drugs on vulnerability to ventricular fibrillationE A Raeder, R L Verrier, B Lown
JAMA|April 7, 1975
Programmed "trendscription." A new approach to electrocardiographic monitoringB Lown, R J Matta, H W Besser
Pageof 27

Showing results (131-140 of 263) with videos related to

Sort By:
Pageof 27
The American Journal of Cardiology|November 1, 1975
Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and releaseP J Axelrod, R L Verrier, B Lown
American Heart Journal|May 1, 1985
Side effects and complications of amiodarone therapyE A Raeder, P J Podrid, B Lown
Circulation Research|May 1, 1979
Central serotonergic agents raise the repetitive extrasystole threshold of the vulnerable period of the canine ventricular myocardiumC M Blatt, S H Rabinowitz, B Lown
The New England Journal of Medicine|September 4, 1980
Respiratory difficulty after use of disopyramideJ G Porterfield, E M Antman, B Lown
Cardiovascular Research|May 1, 1980
Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusionW W Brooks, R L Verrier, B Lown
Cardiovascular Research|March 1, 1978
Protective effect of the vagotonic action of morphine sulphate on ventricular vulnerabilityR A EdSilva, R L Verrier, B Lown
The American Journal of Cardiology|August 1, 1982
Effects of sulfinpyrazone on ventricular vulnerability in the normal and the ischemic heartE A Raeder, R L Verrier, B Lown
Circulation Research|June 1, 1977
Effect of stellectomy and vagotomy on ventricular refractoriness in dogsP J Schwartz, R L Verrier, B Lown
Journal of the American College of Cardiology|June 1, 1983
Intrinsic sympathomimetic activity and the effects of beta-adrenergic blocking drugs on vulnerability to ventricular fibrillationE A Raeder, R L Verrier, B Lown
JAMA|April 7, 1975
Programmed "trendscription." A new approach to electrocardiographic monitoringB Lown, R J Matta, H W Besser
Pageof 27